SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-045105
Filing Date
2024-04-17
Accepted
2024-04-17 16:10:21
Documents
17
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A asmb-20240416.htm   iXBRL DEF 14A 1864585
2 GRAPHIC img191053295_0.jpg GRAPHIC 7504
3 GRAPHIC img191053295_1.jpg GRAPHIC 7504
4 GRAPHIC img191053295_2.jpg GRAPHIC 42417
5 GRAPHIC img191053295_3.jpg GRAPHIC 7504
6 GRAPHIC img191053295_4.jpg GRAPHIC 137553
7 GRAPHIC img191053295_5.jpg GRAPHIC 105779
  Complete submission text file 0000950170-24-045105.txt   3426876

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20240416.xsd EX-101.SCH 22730
20 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20240416_htm.xml XML 221851
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35005 | Film No.: 24851124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)